134 related articles for article (PubMed ID: 8105100)
1. Vaccines discussed at papillomavirus conference.
Larsen NS
J Natl Cancer Inst; 1993 Nov; 85(21):1717-8. PubMed ID: 8105100
[No Abstract] [Full Text] [Related]
2. Human papillomavirus vaccines.
Kahn JA; Bernstein DI
Pediatr Infect Dis J; 2003 May; 22(5):443-5. PubMed ID: 12792387
[No Abstract] [Full Text] [Related]
3. HPV vaccine moves into late stage trials.
Connett H
Nat Med; 2001 Apr; 7(4):388. PubMed ID: 11283639
[No Abstract] [Full Text] [Related]
4. HPV vaccine.
AIDS Patient Care STDS; 1999 Feb; 13(2):76. PubMed ID: 11362122
[No Abstract] [Full Text] [Related]
5. A human papillomavirus type 16 vaccine.
Yoo SS; Whitmore SE
N Engl J Med; 2003 Apr; 348(14):1402-5; author reply 1402-5. PubMed ID: 12678023
[No Abstract] [Full Text] [Related]
6. A human papillomavirus type 16 vaccine.
Schrag SJ; Schuchat A; Schulkin J
N Engl J Med; 2003 Apr; 348(14):1402-5; author reply 1402-5. PubMed ID: 12678020
[No Abstract] [Full Text] [Related]
7. The 18th International Papillomavirus Conference.
Bonnez W
Antivir Ther; 2000 Dec; 5(4):279-83. PubMed ID: 11142623
[No Abstract] [Full Text] [Related]
8. Planning for human papillomavirus vaccines in Australia; report of a research group meeting.
Brotherton JM; McIntyre PB
Commun Dis Intell Q Rep; 2004; 28(2):249-54. PubMed ID: 15460964
[No Abstract] [Full Text] [Related]
9. Human papillomavirus infection and cervical carcinoma.
Kaufman RH; Adam E; Vonka V
Clin Obstet Gynecol; 2000 Jun; 43(2):363-80. PubMed ID: 10863634
[No Abstract] [Full Text] [Related]
10. A human papillomavirus type 16 vaccine.
Duggirala MK; Cuddihy MT
N Engl J Med; 2003 Apr; 348(14):1402-5; author reply 1402-5. PubMed ID: 12672871
[No Abstract] [Full Text] [Related]
11. Papillomavirus vaccines: current status and future prospects.
Schiller JT; Okun MM
Adv Dermatol; 1996; 11():355-80; discussion 381. PubMed ID: 8718484
[No Abstract] [Full Text] [Related]
12. Vaccines for papillomavirus infection.
Frazer I
Virus Res; 2002 Nov; 89(2):271-4. PubMed ID: 12445666
[TBL] [Abstract][Full Text] [Related]
13. [Prophylactic and therapeutic vaccine therapy in papillomavirus infections].
Vinatier D; Cosson M; Dufour P
Gynecol Obstet Fertil; 2000 May; 28(5):370-84. PubMed ID: 10893881
[TBL] [Abstract][Full Text] [Related]
14. A human papillomavirus type 16 vaccine.
Tammela JE; Lele S; Odunsi K
N Engl J Med; 2003 Apr; 348(14):1402-5; author reply 1402-5. PubMed ID: 12678018
[No Abstract] [Full Text] [Related]
15. Multistep carcinogenesis and genital papillomavirus infection. Implications for diagnosis and vaccines.
Rangel LM; RamÃrez M; Torroella M; Pedroza A; Ibarra V; Gariglio P
Arch Med Res; 1994; 25(2):265-72. PubMed ID: 7919824
[TBL] [Abstract][Full Text] [Related]
16. CDC recommends expensive vaccine for all girls aged 11-12.
Tanne J
BMJ; 2006 Jul; 333(7559):114. PubMed ID: 16840454
[No Abstract] [Full Text] [Related]
17. Comparison of papillomavirus and immunodeficiency virus evolutionary patterns in the context of a papillomavirus vaccine.
Halpern AL
J Clin Virol; 2000 Oct; 19(1-2):43-56. PubMed ID: 11091147
[TBL] [Abstract][Full Text] [Related]
18. Vaccinating women against premature death. Proceedings of HPV vaccination workshop. January 10, 2000, Helsinki, Finland.
J Clin Virol; 2000 Oct; 19(1-2):viii-ix, 1-133. PubMed ID: 11091155
[No Abstract] [Full Text] [Related]
19. Use of mature dendritic cells for anti-human papillomavirus peptide-based vaccination in transplant patients.
Mariat C; Alamartine E; Sabido O; Berthoux F
Transplant Proc; 2002 Nov; 34(7):2836-7. PubMed ID: 12431627
[No Abstract] [Full Text] [Related]
20. Vaccinating women against premature death: summary of an International Workshop, Helsinki, Finland, 10.01.2000.
Lehtinen M; Dillner J; Paavonen J
Vaccine; 2001 Jan; 19(11-12):1347-52. PubMed ID: 11252250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
